4,6-Dimethyl-indan-1-on | 1685-81-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 4,6-Dimethyl-indan-1-on
• 英文别名: 4,6-dimethyl-2,3-dihydro-1H-inden-1-one；1H-inden-1-one, 2,3-dihydro-4,6-dimethyl-；4,6-dimethyl-2,3-dihydroinden-1-one
• CAS: 1685-81-0
• 化学式: C₁₁H₁₂O
• 分子量: 160.216
• InChiKey: CXWJSLVFUZGIAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温下应存于干燥密封的环境中。

反应信息

• 作为反应物：
  描述：

  4,6-Dimethyl-indan-1-on 在 Noyori's catalyst 甲酸 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以87%的产率得到(1S)-4,6-dimethylindan-1-ol
  参考文献：
  名称：

  CARBOXYLIC ACID COMPOUND

  摘要：

  寻找具有优异活性和安全性的治疗剂和/或预防剂，用于糖尿病或类似疾病。以下通用式（I）所代表的化合物，或其药理学上可接受的盐。在该式中，X代表 ═C(R5)- 或 ═N—；Y代表 —O— 或 —NH—；L代表键或可替代的C1-C3烷基链；M代表可替代的C3-C10环烷基，可替代的C6-C10芳基，或可替代的杂环基；R1代表C1-C6烷基，C3-C10环烷基，C1-C6卤代烷基，C2-C6烯基，C2-C6炔基，C1-C6脂肪酰基，C1-C6烷氧基C1-C6烷基，或C6-C10芳基；而R2、R3、R4和R5可以相同也可以不同，每个代表氢原子，卤原子，C1-C3烷基，C1-C3卤代烷基，C1-C3烷氧基，或硝基。在这种情况下，R1和R2的烷基基团可以结合在一起形成含有一个氧原子的5-至6-成员杂环环。

  公开号：

  US20110053974A1
• 作为产物：
  描述：

  2,4-二甲基溴苯 在 palladium on activated charcoal 哌啶 、 吡啶 、 lithium aluminium tetrahydride 、 PPA 、 氢气 、 magnesium 、 pyridinium chlorochromate 作用下， 以 1,4-二氧六环 、 乙醚 、 二氯甲烷 为溶剂， 25.0~80.0 ℃ 、206.84 kPa 条件下， 反应 58.0h， 生成 4,6-Dimethyl-indan-1-on
  参考文献：
  名称：

  Aromatische Spirane, 20. Mitt.: Darstellung von dimethylsubstituierten 2-Carboxymethyl-indan-1-onen und Benzylchloriden als Synthone f�r Synthesen von di- bis tetramethylierten 2,2?-Spirobiindandionen

  摘要：

  The isomeric dimethyl methylbenzoates 5, obtained from the bromides via Grignard reactions with dimethylcarbonate, were reduced with LiAlH4 to the hydroxymethyl derivatives 6. The latter were then transformed both to the benzylchlorides 7 (with SOCl2) and to the aldehydes 8 (with pyridinium chlorochromate). Knoevenagel-Doebner reaction of 8 afforded the acrylic acids 9 which (after hydrogenation to 11) were cyclized to the desired indanones 12 with polyphosphoric acid. On the other hand, 12c and 12e were prepared from dimethyl 3-chloropropiophenone (14) by warming with sulfuric acid. After NaH-catalyzed reaction with dimethylcarbonate, the indanones 12 gave the ketoesters 15 which then could be hydrogenated to the indanes 16. All reactions proceeded with satisfactory to excellent yields (60-90%).

  DOI：

  10.1007/bf00807400

文献信息

• [EN] COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT DE TROUBLES DU TRACTUS DIGESTIF
  申请人：ARDELYX INC

  公开号：WO2018129552A1

  公开（公告）日：2018-07-12

  The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.

  本公开涉及化合物和治疗与液体潴留或盐过多有关的疾病的方法，例如心力衰竭（特别是充血性心力衰竭）、慢性肾病、晚期肾病、肝病和过氧化物酶体增殖物激活受体（PPAR）γ激动剂诱导的液体潴留。本公开还涉及化合物和治疗高血压的方法。本公开还涉及化合物和治疗胃肠道疾病的方法，包括治疗或减轻与胃肠道疾病相关的疼痛。
• [EN] PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE<br/>[FR] DÉRIVÉS DE PYRIMIDONE ET LEUR UTILISATION DANS LE TRAITEMENT, LE SOULAGEMENT OU LA PRÉVENTION D'UNE MALADIE VIRALE
  申请人：SAVIRA PHARMACEUTICALS GMBH

  公开号：WO2017158151A1

  公开（公告）日：2017-09-21

  The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease, in particular influenza.

  本发明涉及具有通式（I）的化合物，可选地为药学上可接受的盐、溶剂合物、多晶形、共药、共晶体、前药、互变异构体、消旋体、对映体或二对映体或其混合物，用于治疗、改善或预防病毒性疾病，特别是流感。
• Synthesis of di- and tetraalkyl-3-piperazinoisoquinolines and related compounds as potential antidepressant agents
  作者：Wilhelm Bartmann、Elmar Konz、Wolfgang Rüger

  DOI：10.1002/jhet.5570240326

  日期：1987.5

  A series of di- and tetraalkyl-3-piperazinoisoquinolines and related compounds was synthesized via di- and tetraalkylated 1-indanones as intermediates.

  经由二烷基和四烷基化的1-茚满酮作为中间体合成了一系列二烷基和四烷基-3-哌嗪子异喹啉和相关化合物。
• A Systematic Investigation of Long-Range Couplings in the 1H NMR Spectra of Dimeric Indanones
  作者：Susanne Felsinger、Hermann Kalchhauser、Horst Neudeck

  DOI：10.1007/s007060170136

  日期：2001.2.15

  of 3-phenyl-propionic acids, dimerization led to by-products which can be considered as dimeric indanones. The proton NMR spectra of these compounds exhibit pronounced scalar couplings over up to seven bonds. A series of structures of the above type were investigated, and their NMR spectroscopic behaviour is discussed.

   在通过3-苯基-丙酸的分子内环化合成甲基取代的茚满酮的过程中，二聚作用导致副产物，其可以被认为是二聚茚满酮。这些化合物的质子NMR光谱在多达七个键上显示出明显的标量偶合。研究了上述类型的一系列结构，并讨论了其NMR光谱行为。
• Catalytic Asymmetric Inverse‐Electron‐Demand Diels–Alder Reactions of 2‐Pyrones with Indenes: Total Syntheses of Cephanolides A and B
  作者：Yang Lu、Meng‐Meng Xu、Zhi‐Mao Zhang、Junliang Zhang、Quan Cai

  DOI：10.1002/anie.202112223

  日期：2021.12.13

  Catalytic asymmetric all-carbon-based inverse-electron-demand Diels–Alder reactions of 2-pyrones with electronically unbiased indenes have been realized. This method enables the rapid and enantioselective construction of a wide range of hexahydrofluorenyl bridged-lactone scaffolds. Based on this method, asymmetric total syntheses of cephanolides A and B have been accomplished.

  2-吡喃酮与电子无偏茚的催化不对称全碳基逆电子需求 Diels-Alder 反应已经实现。这种方法能够快速和对映选择性地构建范围广泛的六氢芴基桥接内酯支架。基于该方法，完成了头孢内酯A和B的不对称全合成。

表征谱图